Rare diseases
Investigational molecules
Locations
J. Sutiste Tee 19, Mustamae Linnaosa, 13419 Tallin, Estonia
North Estonia Medical Centre Foundation in Tallin, Estonia specialises in clinical trials of conditions such as Psoriatic arthropathy, Non-small cell lung cancer, Acute myeloid leukaemia, Arteriosclerosis, and other specialisations. This site conducts important research.
The North Estonia Medical Centre Foundation’s nephrology unit is testing innovative treatments to reduce proteinuria and protect renal function in patients with immunoglobulin A nephropathy and other glomerular disorders.
These studies aim to improve long‑term outcomes for individuals with chronic kidney disease and those receiving dialysis.
Researchers are evaluating new immunotherapies and targeted agents to extend survival in a range of malignancies, including non‑small cell lung cancer and hematologic cancers.
The goal is to assess the efficacy of novel drug combinations and improve disease‑free survival across solid tumors and blood cancers.
The centre is conducting trials that explore innovative anticoagulants and lipid‑lowering therapies to lower the risk of major cardiovascular events in high‑risk populations, such as those with atrial fibrillation or elevated genetic risk.
These investigations seek to demonstrate reductions in heart attacks, strokes, and cardiovascular mortality.
Ongoing studies focus on biologic and small‑molecule agents designed to control inflammation in conditions such as psoriatic arthritis and inflammatory bowel disease.
The purpose of these trials is to achieve better symptom control, reduce disease flares, and improve patients’ quality of life.
The site is evaluating new antimicrobial and antifibrotic compounds to treat serious infections and progressive lung diseases, including complicated urinary tract infections and fibrotic interstitial lung disorders.
These trials aim to improve infection cure rates and slow lung function decline in affected patients.
Clinical trials currently enrolling participants at this site.
Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
EstoniaStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
EstoniaStudy of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines
EstoniaStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
EstoniaStudy on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
EstoniaStudy on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
EstoniaA double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis
EstoniaPhase II Study of Teclistamab Plus Pomalidomide in Patients with Relapsed/Refractory Multiple Myeloma After 1–3 Prior Therapies
EstoniaA Study of BI 764532, Atezolizumab, Carboplatin, and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer
EstoniaStudy of blinatumomab and a drug combination for older adults with newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphoblastic Leukemia
EstoniaA study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
EstoniaStudy of glepaglutide compared to placebo for patients with short bowel syndrome with intestinal failure
EstoniaMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
